Abradelo de Usera, Manuel Jiménez Romero, Carlos Loinaz Segurola, Carmelo Moreno González, Enrique
Trasplante hepático con injerto procedente de donación después de muerte cardiocirculatoria controlada. Situacion actual. [artículo] - Cirugía española, 2013 - 91(9):554-62.
Formato Vancouver:
Abradelo De Usera M, Jiménez Romero C, Loinaz Segurola C, Moreno González E. Trasplante hepático con injerto procedente de donación después de muerte cardiocirculatoria controlada. Situacion actual. Cir Esp. 2013 Nov;91(9):554-62.
PMID: 24021972
Contiene 58 referencias
An increasing pressure on the liver transplant waiting list, forces us to explore new sources, in order to expand the donor pool. One of the most interesting and with a promising potential, is donation after cardiac death (DCD). Initially, this activity has developed in Spain by means of the Maastricht type II donation in the uncontrolled setting. For different reasons, donation after controlled cardiac death has been reconsidered in our country. The most outstanding circumstance involved in DCD donation is a potential ischemic stress, that could cause severe liver graft cell damage, resulting in an adverse effect on liver transplant results, in terms of complications and outcomes. The complex and particular issues related to DCD Donation will be discussed in this review.
Trasplante hepático con injerto procedente de donación después de muerte cardiocirculatoria controlada. Situacion actual. [artículo] - Cirugía española, 2013 - 91(9):554-62.
Formato Vancouver:
Abradelo De Usera M, Jiménez Romero C, Loinaz Segurola C, Moreno González E. Trasplante hepático con injerto procedente de donación después de muerte cardiocirculatoria controlada. Situacion actual. Cir Esp. 2013 Nov;91(9):554-62.
PMID: 24021972
Contiene 58 referencias
An increasing pressure on the liver transplant waiting list, forces us to explore new sources, in order to expand the donor pool. One of the most interesting and with a promising potential, is donation after cardiac death (DCD). Initially, this activity has developed in Spain by means of the Maastricht type II donation in the uncontrolled setting. For different reasons, donation after controlled cardiac death has been reconsidered in our country. The most outstanding circumstance involved in DCD donation is a potential ischemic stress, that could cause severe liver graft cell damage, resulting in an adverse effect on liver transplant results, in terms of complications and outcomes. The complex and particular issues related to DCD Donation will be discussed in this review.
